Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)
- PMID: 20847342
- PMCID: PMC2974315
- DOI: 10.1158/0008-5472.CAN-10-1420
Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)
Abstract
Vitamin D has been hypothesized to protect against cancer. We followed 16,819 participants in NHANES III (Third National Health and Nutritional Examination Survey) from 1988 to 2006, expanding on an earlier NHANES III study (1988-2000). Using Cox proportional hazards regression models, we examined risk related to baseline serum 25-hydroxyvitamin D [25(OH)D] for total cancer mortality, in both sexes, and by racial/ethnic groups, as well as for site-specific cancers. Because serum was collected in the south in cooler months and in the north in warmer months, we examined associations by collection season ("summer/higher latitude" and "winter/lower latitude"). We identified 884 cancer deaths during 225,212 person-years. Overall cancer mortality risks were unrelated to baseline 25(OH)D status in both season/latitude groups, and in non-Hispanic whites, non-Hispanic blacks, and Mexican-Americans. In men, risks were elevated at higher levels {e.g., for ≥100 nmol/L, relative risk (RR) = 1.85 [95% confidence interval (CI), 1.02-3.35] compared with <37.5 nmol/L}. Although risks were unrelated to 25(OH)D in all women combined, risks significantly decreased with increasing 25(OH)D in the summer/higher latitude group [for ≥100 nmol/L, RR = 0.52 (95% CI, 0.25-1.15) compared with <37.5 nmol/L; P(trend) = 0.03, based on continuous values]. We also observed a suggestion of an inverse association with colorectal cancer mortality (P(trend) = 0.09) and a positive association with lung cancer mortality among males (P(trend) = 0.03). Our results do not support the hypothesis that 25(OH)D is associated with reduced cancer mortality. Although cancer mortality in females was inversely associated with 25(OH)D in the summer/higher latitude group, cancer mortality at some sites was increased among men with higher 25(OH)D. These findings argue for caution before increasing 25(OH)D levels to prevent cancer.
©2010 AACR.
Similar articles
-
Prospective study of serum vitamin D and cancer mortality in the United States.J Natl Cancer Inst. 2007 Nov 7;99(21):1594-602. doi: 10.1093/jnci/djm204. Epub 2007 Oct 30. J Natl Cancer Inst. 2007. PMID: 17971526
-
Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III.Bone. 2002 May;30(5):771-7. doi: 10.1016/s8756-3282(02)00692-0. Bone. 2002. PMID: 11996918
-
Consistent ethnic specific differences in diabetes risk and vitamin D status in the National Health and Nutrition Examination Surveys.J Steroid Biochem Mol Biol. 2016 Nov;164:4-10. doi: 10.1016/j.jsbmb.2015.09.023. Epub 2015 Sep 16. J Steroid Biochem Mol Biol. 2016. PMID: 26386461
-
Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women.Am J Clin Nutr. 2004 Dec;80(Suppl 6):1763S-6S. doi: 10.1093/ajcn/80.6.1763S. Am J Clin Nutr. 2004. PMID: 15585802 Review.
-
Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States.J Am Med Dir Assoc. 2010 Nov;11(9):617-28. doi: 10.1016/j.jamda.2010.03.013. J Am Med Dir Assoc. 2010. PMID: 21029996 Review.
Cited by
-
Association between Vitamin D Supplementation and Cancer Mortality: A Systematic Review and Meta-Analysis.Cancers (Basel). 2022 Jul 30;14(15):3717. doi: 10.3390/cancers14153717. Cancers (Basel). 2022. PMID: 35954381 Free PMC article. Review.
-
The Relationship between VDR Gene Polymorphisms Bsm1 and Apa1 with Breast Cancer Risk.Glob Med Genet. 2024 Mar 4;11(1):69-75. doi: 10.1055/s-0044-1779040. eCollection 2024 Jan. Glob Med Genet. 2024. PMID: 38440355 Free PMC article.
-
Prediagnostic Serum Vitamin D, Vitamin D Binding Protein Isoforms, and Cancer Survival.JNCI Cancer Spectr. 2022 Mar 2;6(2):pkac019. doi: 10.1093/jncics/pkac019. JNCI Cancer Spectr. 2022. PMID: 35603848 Free PMC article.
-
Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence.J Cancer. 2016 Jan 5;7(3):232-40. doi: 10.7150/jca.13403. eCollection 2016. J Cancer. 2016. PMID: 26918035 Free PMC article. Review.
-
Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges.Epidemiol Rev. 2017 Jan 1;39(1):28-48. doi: 10.1093/epirev/mxx005. Epidemiol Rev. 2017. PMID: 28486651 Free PMC article. Review.
References
-
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. - PubMed
-
- Giovannucci E, Liu Y, Willett WC. Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2467–2472. - PubMed
-
- Egan KM, Signorello LB, Munro HM, Hargreaves MK, Hollis BW, Blot WJ. Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States) Cancer Causes Control. 2008;19(5):527–535. - PubMed
-
- Grant WB. Differences in vitamin-D status may explain black-white differences in breast cancer survival rates. Journal of the National Medical Association. 2008;100(9):1040. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical